Aller directement au contenu principal

Écrire un commentaire

PREreview de Combination Therapy in Hypertension: Renin-Angiotensin-Aldosterone System Inhibitor with a Diuretic or Calcium Channel Blocker

Publié
DOI
10.5281/zenodo.17259940
Licence
CC BY 4.0

This paper’s goal was to comparatively analysis the most frequently used combination: RAAS inhibitor with diuretics or a calcium channel blocker. This is a very good study because combination therapy is better than one therapy. The topic is relevant and addresses significant public health issues. However, the abstract talks mainly about the background and does not balance with other sections, such as methods, results, and conclusions.

Methods

I am not sure what methods were used to arrive at the presented findings, as this is not clear in the manuscript. I would appreciate it if the author could clarify this clearly, providing details on sampling methods, inclusion, and exclusion criteria. This will help clarify other sections of the manuscript.

Competing interests

The authors declare that they have no competing interests.

Use of Artificial Intelligence (AI)

The authors declare that they did not use generative AI to come up with new ideas for their review.

Vous pouvez rédiger un commentaire sur ce PREreview de Combination Therapy in Hypertension: Renin-Angiotensin-Aldosterone System Inhibitor with a Diuretic or Calcium Channel Blocker.

Avant de commencer

Nous vous demanderons de vous connecter avec votre identifiant ORCID iD. Si vous n'en avez pas, vous pouvez en créer un.

Qu’est-ce qu’un ORCID iD ?

Un ORCID iD est un identifiant unique qui vous distingue de toute personne ayant le même nom ou nom similaire.

Commencer maintenant